BDBM655796 2-acetamido-4-((1-(4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-2-oxo-6,9,12,15,18-pentaoxa-3-azaicosan-20-yl)amino)-N-(4-methyl-5-nitrothiazol-2-yl)benzamide::US20240066136,Compound D-48

SMILES CC(=O)Nc1cc(NCCOCCOCCOCCOCCOCCNC(=O)CN2CCN(CC2)c2ccc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)nc2)ccc1C(=O)Nc1nc(C)c(s1)[N+]([O-])=O

InChI Key InChIKey=RQRRAXJMKLCWQM-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 655796   

TargetDNA damage-binding protein 1(Human)
Cullgen (Shanghai)

US Patent
LigandPNGBDBM655796(US20240066136,Compound D-48 | 2-acetamido-4-((1-(4...)
Affinity DataKd: <2.00E+4nMAssay Description:Surface plasmon resonance (SPR) binding assay. All SPR studies were performed on a Biacore X100 plus or T200 instrument (GE Healthcare). Immobilizati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent